Insight Molecular Diagnostics (IMDX) P/E (2016 - 2026)
Insight Molecular Diagnostics (IMDX) P/E from Jan 4, 2016 to Jul 21, 2026. The TTM Insight Molecular Diagnostics (IMDX) P/E is -3.03. You can export chart.
All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.
P/E
Annual P/E change of Insight Molecular Diagnostics (IMDX)
| Year | P/E | Change |
|---|---|---|
| 2026 | -3.03 | -29.28% |
| 2025 | -4.28 | +685.89% |
| 2024 | -0.54 | +93.20% |
| 2023 | -0.28 | -42.98% |
| 2022 | -0.49 | -84.08% |
| 2021 | -3.10 | -41.37% |
| 2020 | -5.30 | -1.72% |
| 2019 | -5.39 | +55.32% |
| 2018 | -3.47 | -54.01% |
| 2017 | -7.54 | -52.41% |
| 2016 | -15.85 | N/A |
Comparison Insight Molecular Diagnostics (IMDX) P/E with competitors
Insight Molecular Diagnostics (IMDX) P/E is -3.03.
| Ticker | Name | P/E | Upside |
|---|---|---|---|
| ADVB | Advanced Biomed Inc | 1.05 | -134.65% |
| MBAI | CheckCap Ltd | 1.71 | -156.60% |
| FONR | Fonar Corp | 15.48 | -611.52% |
| QGEN | Qiagen NV | 20.03 | -761.94% |
| DGX | Quest Diagnostics Inc | 22.47 | -842.69% |
| LH | Laboratory Corp Of America Holdings | 23.87 | -888.88% |
| IQV | IQVIA Holdings Inc | 25.28 | -935.54% |
| A | Agilent Technologies Inc | 26.96 | -990.90% |
| TMO | Thermo Fisher Scientific Inc | 31.53 | -1141.96% |
| MTD | Mettler-Toledo International Inc | 32.45 | -1172.41% |
| MEDP | Medpace Holdings Inc | 32.55 | -1175.70% |
| DHR | Danaher Corp | 38.55 | -1374.10% |
| IDXX | Idexx Laboratories Inc | 40.58 | -1440.92% |
| RVTY | Revvity Inc | 52.68 | -1840.98% |
| VCYT | Veracyte Inc | 53.71 | -1875.05% |
| ICLR | Icon Plc | 57.45 | -1998.63% |
| SHC | Sotera Health Company | 74.08 | -2548.31% |
| WAT | Waters Corp | 102.79 | -3496.83% |